Vantage point: Investing in innovationAug 24 2023

Where the value is in Biotech right now

twitter-iconfacebook-iconlinkedin-iconmail-iconprint-icon
Search supported by
Where the value is in Biotech right now
Ailsa Craig jointly runs the International Biotech investment trust
comment-speech

The valuations of companies in the biotechnology sector remain below their peak in 2021, but while some recovery is happening, the opportunity is no longer at the large cap area of the market, according to Ailsa Craig, who jointly runs the International Biotech investment trust.

Unlimited access to our award-winning journalism

Read the full story with a free account

  • Read without interruption - full access to our reporting on the financial intermediary market
  • Bank CPD while you read
  • Share your perspectives
  • Stay in the know with our daily newsletter
  • Receive personal recommendations
Already have an account?Sign In

Related articles

Related Topics

Adviser technology
Investment trusts
Investments
Large caps
Small caps
A service from the Financial Times